Callisto Pharmaceuticals, Inc.
Industry
- Pharmaceuticals
- Biotechnology
Latest on Callisto Pharmaceuticals, Inc.
Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog. The U.S./German biotech Agennix AG announced
IN VITRO DIAGNOSTICS Mergers & Acquisitions Life Technologies Corp. Navigenics Inc. In an initial move to build up its molecular diagnostics business, Life Technologies Corp. is buying privately h
Nasdaq-listed Synergy Pharmaceuticals has raised just under $14 million after expenses in a public offering of shares and warrants. The company said it would use some of the proceeds to fund its gastr
Ironwood Pharmaceuticals has raised $50 million in private equity financing primarily to support the development of linaclotide, its Phase III gastrointestinal compound. The money will fund linaclotid